Cell and Tissue Preservation Market Share, Size, Trends, Industry Analysis Report, By Type (Cell, Tissue); By Product (Equipment, Bio-preservation, Software); By End-Use; By Region; Segment Forecast, 2022 - 2030
- Published Date:Sep-2022
- Pages: 112
- Format: PDF
- Report ID: PM2589
- Base Year: 2021
- Historical Data: 2018-2020
Report Outlook
The cell and tissue preservation market were valued 3.47 billion in 2021 and is expected to grow at a CAGR of 10.5% during the forecast period. The demand for cell and tissue preservation market is expected to be driven by the increase in biobanks preserving more samples of tissues leading to development activities for innovative drugs to treat various diseases.
Know more about this report: Request for sample pages
The demand is mainly driven because of advantages related to the preservation of stem cells and government investment in developing infrastructure in healthcare sectors across developing and developed nations. Furthermore, the growing demand for the freezer in the equipment segment is rising as it is intended to maintain the viability of biological materials, reduce genetic mutations, and reduce crystal formulation is expected to positively impact the industry growth.
The COVID-19 pandemic positively impacted the growth of the cell and tissue preservation market. The rise in regenerative preservation therapies, which are helpful to preserve samples, fuel market growth. Furthermore, the restoration of many organs with the help of freezers and heating devices, which almost reduce the risk of contamination, has significantly driven the industry's growth.
As the emerging new and advanced technologies to preserve the tissues in the developing economies grew, post-pandemic time steadily led to the demand for tissue preservation in countries such as China, India, and Mexico, among others. In addition, the rising disposable income and demand for better healthcare facilities in the Asia Pacific are likely to complement market growth over the forecast period.
Know more about this report: Request for sample pages
Industry Dynamics
Growth Drivers
The worldwide cell and tissue preservation market is likely to be driven by the demand in the Asia Pacific owing to the increasing government investment in research activities in India and China. Furthermore, the rising need for regenerative preservation and the rise in the number of patients dealing with many cardiovascular diseases are likely to positively impact the industry growth for the product.
Many innovations, such as the development in the storage of samples with proper heat and cooling temperatures, are also expected to boost the industry's growth. In addition, this innovation has created many opportunities to preserve many complex samples of tissues and organs for a long time, which will be helpful while performing surgeries that fuel industry growth.
Report Segmentation
The market is primarily segmented based on type, product, Application, end-use, and region.
|
By Type |
By Product |
By Application |
By End-Use |
By Region |
|
|
|
|
|
Know more about this report: Request for sample pages
Tissue segment accounted for the largest share in 2021
The tissue market segment accounted for the highest revenue share in 2021 owing to the increasing investments in R&D departments, which require collecting, process, and preserving the samples for better treatments.
Moreover, the rising prevalence of severe injuries and many age-related diseases are some of the reasons to maintain tissues and drive the growth of the industry. In addition, the increasing demand for regenerative preservation, which includes blood, and organs, and their long-term healing factors are significantly stimulating market growth over the forecast period.
Cell type is also expected to grow during the forecast period, owing to a lot of advancement in preservation methods and the increasing level of diseases in developed and developing countries, and the adoption of regenerative therapies is driving the growth of the market.
Equipment segment is expected to spearhead the market growth
The demand for the equipment segment is driven by the rising need to maintain a steady supply of genetically stable live cells for various medical procedures. In addition, the equipment segment is segmented into freezers and thawing system, of which freezers demand are growing owing to usage in various medical activities like bone marrow transplant and many medical procedures, which requires the samples to be cooled and frozen. Furthermore, the adoption of ingenious and advanced equipment has propelled market growth.
The software segment is projected to witness growth owing to the rise in digitization and the technology which provides cost-efficiency and operates efficiently with optimum inventory, leading to the adoption of software technologies which is expected to drive revenue growth over the forecast period.
Therapeutics is expected to witness faster growth in the forecast period
The demand for therapeutics is expected to see a significant surge over the forecast period owing to the increasing advancement in the development of various medicines related to non-communicable and non-curable diseases, which has raised the demand for the therapeutics market. The growing incidences of many lifestyles and age-related illnesses will contribute to the development of tissue preservation and propel the growth of the market.
Biobanks segment is expected to account for the largest share in 2030
The biobanks segment is expected to dominate the market over the forecast period owing to the increasing adoption of preservations for therapeutics applications across the pharma and healthcare sectors. The growing need for biobanks is increasing in reproductive technologies where both the male and female gametes are preserved for further medical procedures, which is likely to have a positive impact on revenue growth over the forecast period.
Hospitals are expected to be one of the other significant applications for the cell and tissue preservation market owing to the availability of biospecimen while performing surgeries for any part of the body. The adoption of advanced technologies in the healthcare sector is fueling the demand in this segment.
North America is expected to dominate and witness fastest growth over the forecast period
North America is the largest region for tissue preservation. It is expected to witness faster growth over the forecast period owing to the investments done by the governments in R&D activities across the countries. In addition, many pharma companies' growing involvement in commodifying preservation devices and well-established healthcare infrastructure is expected to drive demand over the forecast period.
The Asia Pacific is expected to be the second largest tissue preservation region because of the growing need for unmet biomedical illnesses. Furthermore, the increasing investment in developing the healthcare sector with the introduction of new and innovative technologies and pharmaceutical companies collaborating with CROs is likely to positively impact growth.
Competitive Insight
Some of the major players operating in the global market include Agilent Technologies,Inc., AMSBIO, Avantor, Inc.,BD, Biocision, Biomatrica, Biolife solutions,Inc., CellGenix GmbH, Corning Incorporated, Chart MVE Biomedical, Cytiva, FUJIFILM Irvine Scientific, LGC Seracare, Lonza, Merck KGaA, Princeton Cryotech, STEMCELL Technologies Inc., ThermoFisher Scientific, Inc.
Recent Developments
In September 2021, Biolife Solutions announced the acquisition of Scisafe, which stores many cells and genes with its biological material storage system, which will store cells and genes and will improve their value with great quality.
In February 2021, Cryocell International, Inc. announced an exclusive agreement with Duke University, which will expand to innovate novel therapies for cerebral palsy and autism where the treatments use regenerative properties to treat the patients.
Cell and Tissue Preservation Market Report Scope
|
Report Attributes |
Details |
|
Market size value in 2021 |
USD 3.47 billion |
|
Revenue forecast in 2030 |
USD 8.32 billion |
|
CAGR |
10.5% from 2022 - 2030 |
|
Base year |
2021 |
|
Historical data |
2018 - 2020 |
|
Forecast period |
2022 - 2030 |
|
Quantitative units |
Revenue in USD billion and CAGR from 2022 to 2030 |
|
Segments covered |
By Type, By Product, By Application, By End-Use, and By Region |
|
Regional scope |
North America, Europe, Asia Pacific, Latin America; Middle East & Africa |
|
Key companies |
Agilent Technologies,Inc., AMSBIO, Avantor, Inc.,BD, Biocision, Biomatrica, Biolife solutions,Inc., CellGenix GmbH, Corning Incorporated, Chart MVE Biomedical, Cytiva, FUJIFILM Irvine Scientific, LGC Seracare, Lonza, Merck KGaA, Princeton Cryotech, STEMCELL Technologies Inc., ThermoFisher Scientific, Inc. |
© 2024 Polaris Market Research and Consulting. All rights reserved
